References
- Verma A, St Clair EW, Radtke RA. A case of sustained massive gabapentin overdose without serious side effects. Ther Drug Monit. 1999;21:615–617.
- Bryans JS, Davies N, Gee NS, et al. Identification of novel ligands for the gabapentin binding site on the alpha2delta subunit of a calcium channel and their evaluation as anticonvulsant agents. J Med Chem. 1998;41:1838–1845.
- Belliotti TR, Capiris T, Ekhato IV, et al. Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein. J Med Chem. 2005;48:2294–2307.
- Middleton O. Suicide by gabapentin overdose. J Forensic Sci. 2011;56:1373–1375.
- Chen C. Meta-analyses of dose-exposure relationships for gabapentin following oral administration of gabapentin and gabapentin enacarbil. Eur J Clin Pharmacol. 2013;69:1809–1817.
- Klein-Schwartz W, Shepherd JG, Gorman S, et al. Characterization of gabapentin overdose using a poison center case series. J Toxicol Clin Toxicol. 2003;41:11–15.
- Moore A, Derry S, Wiffen P. Gabapentin for chronic neuropathic pain. JAMA. 2018;319:818–819.
- Miller A, Price G. Gabapentin toxicity in renal failure: the importance of dose adjustment. Pain Med. 2009;10:190–192.
- Sirven JI. New uses for older drugs: the tales of aspirin, thalidomide, and gabapentin. Mayo Clin Proc. 2010;85:508–511.
- Shanthanna H, Gilron I, Rajarathinam M, et al. Benefits and safety of gabapentinoids in chronic low back pain: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2017;14:e1002369.
- Mowry JB, Spyker DA, Cantilena LR, Jr, et al. Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th annual report. Clin Toxicol. 2013;51:949–1229.
- Director of the Kentucky Poison Control Center (Dr. Ashley Webb). Personal Communication. Kentucky Poison Control Center of Norton Children’s Hospital; 2017.
- Kentucky Board of Medical Licensure. Summary of HB 1. Kentucky Board of Medical Licensure; 2012. p. 1–6. Available from: http://www.kbml.ky.gov.
- Freeman PR, Goodin A, Troske S, et al. Kentucky House Bill 1 Impact Evaluation: Executive Summary. College of Pharmacy, University of Kentucky: Institute for Pharmaceutical Outcomes and Policy; 2015. p.1–6.
- Schifano F. Misuse and abuse of pregabalin and gabapentin: cause for concern? CNS Drugs. 2014;28:491–496.
- Johansen ME. Gabapentinoid use in the United States 2002 through 2015. JAMA Internal Medicine. Published online January 2, 2018. DOI:10.1001/jamainternmed.2017.7856.
- Chiappini S, Schifano F. A decade of gabapentinoid misuse: an analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ Database. CNS Drugs. 2016;30:647–654.
- Knoppert D. The worldwide opioid epidemic: implications for treatment and research in pregnancy and the newborn. Paediatr Drugs. 2011;13:277–279.
- World Health Organization. Opiates World Health Organization. 2018 [cited 2018 July 20]. Available from: http://www.who.int/substance_abuse/facts/opiates/en/
- Gummin DD, Mowry JB, Spyker DA, et al. 2016 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 34th annual report. Clin Toxicol. 2017;55:1072–1252.
- Schauer SG, Varney SM. Gabapentin overdose in a military beneficiary. Mil Med. 2013;178:133–135.
- Shea YF, Mok MM, Chang RS. Gabapentin-induced myoclonus in an elderly with end-stage renal failure. J Formos Med Assoc. 2014;113:660–661.
- Rasimas JJ, Burkhart KK. Cardiac conduction disturbances after an overdose of nefazodone and gabapentin. Am J Emerg Med. 2006;24:886–888.
- Hedegaard HWM, Miniño AM. Drug overdose deaths in the United States, 1999–2016. NCHS Data Brief, no 294. Hyattsville (MD): National Center for Health Statistics. 2017/CDC. Wide-ranging online data for epidemiologic research (WONDER). Atlanta (GA): CDC, National Center for Health Statistics; 2016. Available at http://wonder.cdc.gov
- Kentucky Office of Drug Control Policy. 2016. Overdose Fatality Report. Kentucky Office of Drug Control Policy: Commonwealth of Kentucky, Justice and Public Safety Cabinet. p. 1–27.